Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative radiotherapy with integrated boost vs chemoradiotherapy for T3-4 rectal cancer
2011-005638-20Phase 3Completed
- Sponsor
- Centro di Riferimento Oncologico di Aviano
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of capecitabine in rectal adenocarcinoma and rectal cancer (2 arms), sponsored by Centro di Riferimento Oncologico di Aviano. Primary endpoint: Non-inferiority of preoperative fluoropyrimidine-based radiotherapy strategy. Started Mar 2012; status: completed.
02
Drugs
capecitabine
03
Conditions
rectal adenocarcinomarectal cancer
Beyond the preview
Go deeper on 2011-005638-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005638-20.